Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Timp1 Promotes Cell Survival by Activating the PDK1 Signaling Pathway in Melanoma

Texto completo
Autor(es):
Toricelli, Mariana ; Melo, Fabiana H. M. ; Hunger, Aline ; Zanatta, Daniela ; Strauss, Bryan E. ; Jasiulionis, Miriam G.
Número total de Autores: 6
Tipo de documento: Artigo Científico
Fonte: CANCERS; v. 9, n. 4 APR 2017.
Citações Web of Science: 9
Resumo

High TIMP1 expression is associated with poor prognosis in melanoma, where it can bind to CD63 and beta 1 integrin, inducing PI3-kinase pathway and cell survival. Phosphatidylinositol (3,4,5)-trisphosphate (PIP3), generated under phosphatidylinositol-3-kinase (PI3K) activation, enables the recruitment and activation of protein kinase B (PKB/AKT) and phosphoinositide-dependent kinase 1 (PDK1) at the membrane, resulting in the phosphorylation of a host of other proteins. Using a melanoma progression model, we evaluated the impact of Timp1 and AKT silencing, as well as PI3K, PDK1, and protein kinase C (PKC) inhibitors on aggressiveness characteristics. Timp1 downregulation resulted in decreased anoikis resistance, clonogenicity, dacarbazine resistance, and in vivo tumor growth and lung colonization. In metastatic cells, pAKT(Thr308) is highly expressed, contributing to anoikis resistance. We showed that PDK1(Ser241) and PKC beta IISer660 are activated by Timp1 in different stages of melanoma progression, contributing to colony formation and anoikis resistance. Moreover, simultaneous inhibition of Timp1 and AKT in metastatic cells resulted in more effective anoikis inhibition. Our findings demonstrate that Timp1 promotes cell survival with the participation of PDK1 and PKC in melanoma. In addition, Timp1 and AKT act synergistically to confer anoikis resistance in advanced tumor stages. This study brings new insights about the mechanisms by which Timp1 promotes cell survival in melanoma, and points to novel perspectives for therapeutic approaches. (AU)

Processo FAPESP: 11/12306-1 - Mecanismos epigenéticos como mediadores da transformação maligna de melanócitos associada a condições sustentadas de estresse
Beneficiário:Miriam Galvonas Jasiulionis
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 10/18715-8 - Determinação das vias de sinalização ativadas pelo complexo CD63, Timp1 e B1-integrinas ao longo da gênese do melanoma
Beneficiário:Mariana Toricelli Pinto
Linha de fomento: Bolsas no Brasil - Doutorado
Processo FAPESP: 14/13663-0 - Integração de dados de expressão de genes e microRNAs, metiloma e hidroximetiloma de diferentes etapas da progressão do melanoma.
Beneficiário:Miriam Galvonas Jasiulionis
Linha de fomento: Auxílio à Pesquisa - Regular